None listed
Conditions
Interventions
Intervention1: CosmeRNA ARI Intensive Anti-Hair loss Tonic: The test product will be applied on site for period of 25 weeks.
Gently scale the scalp to remove excess buildup and ensure its completely
Sponsors
Bioneer
Eligibility
Inclusion criteria
Inclusion criteria: 1) Subjects in the age group 30-50 years (both the ages inclusive). 2) Subjects complaining of hair fall and damage. 3) Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol. 4) Subjects who agree to use regular shampoo throughout the study (shampoo without any hair growth ingredient). 5) Atleast 6 subjects, 3 subjects in each group willing to undergo Biopsy (Subjects who agree to participate in scalp biopsy have to acknowledge and understand of scalp biopsy procedure and potential risks.
Exclusion criteria
Exclusion criteria: 1) Subjects who have undergone any kind of hair growth treatment in the last 1 month. 2) Subjects having any active but controllable scalp disease which may interfere in the study assessments. 3) Subjects who have taken chemotherapy for cancer in the 6 months prior to the study start. 4) Subjects who have history of crash dieting and or psychiatric disorder including trichotillomania. 5) Subjects who have undergone hair transplant. 6) A known history or present condition of allergic response hypersensitivity to any topical or oral cosmetic pharmaceutical or neutraceutical product. 7) Subjects with chronic illness which may influence the cutaneous state. 8) Subjects who are pregnant or nursing (Self declared)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of the test product in promoting hair growth in comparison to baseline determined by dermatological and instrumental assessment.Timepoint: Day 0, Day 2, Day 14, Day 28, Day 30, Day 42, Day 56, Day 58, Day 70, Day 84, Day 86, Day 98, Day 112, Day 114, Day 140, Day 142, Day 168, Day 170 | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the overall safety of the test productTimepoint: Day 0, Day 2, Day 14, Day 28, Day 30, Day 42, Day 56, Day 58, Day 70, Day 84, Day 86, Day 98, Day 112, Day 114, Day 140, Day 142, Day 168, Day 170 | — |
Countries
India
Contacts
Public ContactSudhanthiran S
MS Clinical Research Pvt. Ltd
Outcome results
None listed